CARMEN MAY: Open Payments
NPI 1043264294 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 7 payments from 5 companies in 2025. Trend: 2023 $2,393 · 2024 $1,560 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $260 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $136 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $78 |
Products named: REPATHA, NUZYRA, UPTRAVI, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
